The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabine

por Lazenby, M., Hills, R., Burnett, A.K., Zabkiewicz, J.
Publicado 2015

The prognostic significance of trisomy 4 in acute myeloid leukaemia is dependent on age and additional abnormalities

por Chilton, L, Hills, R K, Burnett, A K, Harrison, C J
Publicado 2016

Analysis of the interaction of induction regimens with p-glycoprotein expression in patients with acute myeloid leukaemia: results from the MRC AML15 trial

por Pallis, M, Hills, R, White, P, Grundy, M, Russell, N, Burnett, A
Publicado 2011

Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients

por Simpson, K., Jones, R.E., Grimstead, J.W., Hills, R., Pepper, C., Baird, D.M.
Publicado 2015

Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3(+) regulatory T cells

por Coles, S J, Hills, R K, Wang, E C Y, Burnett, A K, Man, S, Darley, R L, Tonks, A
Publicado 2012

Expression of CD200 on AML blasts directly suppresses memory T-cell function

por Coles, S J, Hills, R K, Wang, E C Y, Burnett, A K, Man, S, Darley, R L, Tonks, A
Publicado 2012

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

por Burnett, A K, Hills, R K, Nielsen, O J, Freeman, S, Ali, A, Cahalin, P, Hunter, A, Thomas, I F, Russell, N H
Publicado 2018

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia

por Burnett, A K, Russell, N H, Hills, R K, Kell, J, Nielsen, O J, Dennis, M, Cahalin, P, Pocock, C, Ali, S, Burns, S, Freeman, S, Milligan, D, Clark, R E
Publicado 2017